Huron Consulting Group Inc. (NASDAQ:HURN) Director H Eugene Lockhart Sells 1,042 Shares

Huron Consulting Group Inc. (NASDAQ:HURN) Director H Eugene Lockhart sold 1,042 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $125.15, for a total value of $130,406.30. Following the completion of the sale, the director now directly owns 24,672 shares of the company’s stock, valued at approximately $3,087,700.80. The trade was a 4.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

H Eugene Lockhart also recently made the following trade(s):

• On Monday, December 2nd, H Eugene Lockhart sold 1,042 shares of Huron Consulting Group stock. The shares were sold at an average price of $122.81, for a total transaction of $127,968.02.

Huron Consulting Group Stock Performance

HURN stock traded up $1.41 during mid-day trading on Wednesday, reaching $126.17. 14,256 shares of the stock traded hands, compared to its average volume of 88,857. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. The business has a 50-day moving average of $124.31 and a two-hundred day moving average of $115.33. The firm has a market capitalization of $2.24 billion, a PE ratio of 27.42 and a beta of 0.59. Huron Consulting Group Inc. has a 52 week low of $84.26 and a 52 week high of $133.96.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HURN. Benchmark restated a “buy” rating and set a $140.00 price target on shares of Huron Consulting Group in a report on Wednesday, October 30th. StockNews.com upgraded Huron Consulting Group from a “hold” rating to a “buy” rating in a report on Thursday, October 31st. Barrington Research upped their price target on Huron Consulting Group from $137.00 to $142.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Finally, Wedbush began coverage on Huron Consulting Group in a research note on Monday. They issued an “outperform” rating on the stock. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $133.00.

Institutional Trading of Huron Consulting Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Heck Capital Advisors LLC bought a new stake in shares of Huron Consulting Group in the fourth quarter valued at approximately $33,000. Assetmark Inc. boosted its holdings in Huron Consulting Group by 7.0% in the 3rd quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock valued at $149,000 after purchasing an additional 90 shares during the period. MML Investors Services LLC acquired a new stake in Huron Consulting Group in the 3rd quarter worth $220,000. Peapack Gladstone Financial Corp bought a new position in shares of Huron Consulting Group during the 3rd quarter worth about $220,000. Finally, Dakota Wealth Management grew its holdings in shares of Huron Consulting Group by 4.0% during the 4th quarter. Dakota Wealth Management now owns 2,250 shares of the business services provider’s stock worth $280,000 after purchasing an additional 87 shares in the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.